These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


370 related items for PubMed ID: 21270926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
    Fernandes P, Lopes JA, Correia L, Gonçalves S, Jorge S.
    Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G, Nagasaka S, Higo S, Kajimoto Y, Kanemitsu T, Aoki M, Nagahama K, Natori Y, Tsuboi N, Yokoo T, Shimizu A.
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J, Vizjak A, Ferluga D, Kovac D, Ales A, Kveder R, Ponikvar R, Bren A.
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Membranous glomerulonephritis associated with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Zhou GY.
    Nefrologia; 2012 Jul 17; 32(4):548-51. PubMed ID: 22806300
    [No Abstract] [Full Text] [Related]

  • 11. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW.
    Am J Kidney Dis; 2005 Aug 17; 46(2):253-62. PubMed ID: 16112043
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Goodpasture's syndrome with neurologic involvement and negative ANCA].
    Pérez-Suárez G, Marrero D, Rodríguez R, Delgado P, Cobo M, González-Posada JM, Hernández D.
    Nefrologia; 2010 Aug 17; 30(5):584-7. PubMed ID: 20613848
    [Abstract] [Full Text] [Related]

  • 15. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
    Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY.
    J Am Soc Nephrol; 2007 Apr 17; 18(4):1338-43. PubMed ID: 17329569
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
    Little MA, Pusey CD.
    J Nephrol; 2004 Apr 17; 17 Suppl 8():S10-9. PubMed ID: 15599880
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I, Stancu S, Avram A, Taran L, Mircescu G.
    BMC Nephrol; 2015 Jun 30; 16():90. PubMed ID: 26123651
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.